web セミナー Axcelead Broadcasting 日本発の医薬品創出にかける熱い思いがここに「新しい作用機序の化合物探索を実現する Axceleadのフェノティピックスクリーニング」演者:Axcelead Drug Discovery Partners株式会社 医薬探索研究 主席研究員 尾野晃人
previous arrow
next arrow

Axcelead is the first integrated drug discovery solutions provider in the pharmaceutical industry in Japan, having inherited the unique and comprehensive capabilities of drug discovery from Takeda Pharmaceutical Company Limited: “Experienced Scientists”, “Cutting-edge Technology Platform”, and “Huge Historical Drug Discovery Data”, and started its business in 2017.

Looking for a solution in terms of a specific research theme, stage or modality

Solutions for Individual Subjects

Solutions for
Individual Subjects

Axcelead offers the optimum solution in line with your research theme

Click here for details
Integrated Drug Discovery

Integrated Drug

Axcelead offers fully integrated drug discovery services from target discovery to IND enabling translational research

Click Here for Details
New Modalities

New Modalities

The new modalities support epoch-making discovery research including breakthroughs in regenerative medicine, nucleic acids and peptide drug discovery

Click Here for Details
Consulting services

Consulting services

Our highly experienced and expert staff will take care of your non-clinical development strategy and work to solve any problems

Click Here for Details

One-stop shop for human genome knock-in (KI) mouse/rat assessment services

Knockin Mice and Rats

Knockin Mice & Rats

Human genome KI mice and rats is useful for the evaluation of new modality and small molecule in cases where efficacy has not been demonstrated on any other species.


For clients interested in out-licensing

Out-License Program

Out-License Program

Aimed at bio-venture capitalists, academia, and companies planning to enter the pharmaceutical industry who wish to out-license

Click Here for Details


Check out our latest scientific research, insights and passion for drug discovery.


We enjoy the patronage of more than 100 facilities, including pharmaceutical companies, startups and academic institutions